The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... PLoS Medicine 4, e296, 2007 | 57796* | 2007 |
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Annals of internal medicine 151 (4), W-65-W-94, 2009 | 51401 | 2009 |
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials D Moher, S Hopewell, KF Schulz, V Montori, PC Gøtzsche, PJ Devereaux, ... Bmj 340, 2010 | 30577* | 2010 |
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials JPT Higgins, DG Altman, PC Gotzsche, P Juni, D Moher, AD Oxman BMJ 343, d5928, 2011 | 29472 | 2011 |
SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 6279 | 2013 |
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations B Hutton, G Salanti, DM Caldwell, A Chaimani, CH Schmid, C Cameron, ... Annals of internal medicine 162 (11), 777-784, 2015 | 5577 | 2015 |
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ... Bmj 346, 2013 | 4926 | 2013 |
The revised CONSORT statement for reporting randomized trials: explanation and elaboration DG Altman, KF Schulz, D Moher, M Egger, F Davidoff, D Elbourne, ... Annals of internal medicine 134 (8), 663-694, 2001 | 4680 | 2001 |
Screening for breast cancer with mammography PC Gøtzsche, KJ Jørgensen Cochrane database of systematic reviews, 2013 | 3443* | 2013 |
Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment A Hróbjartsson, PC Gøtzsche New England Journal of Medicine 344 (21), 1594-1602, 2001 | 2144 | 2001 |
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles AW Chan, A Hróbjartsson, MT Haahr, PC Gøtzsche, DG Altman Jama 291 (20), 2457-2465, 2004 | 2115 | 2004 |
Meta-analysis of short term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis PC Gøtzsche, HK Johansen Bmj 316 (7134), 811-818, 1998 | 1839* | 1998 |
Better reporting of harms in randomized trials: an extension of the CONSORT statement JPA Ioannidis, SJW Evans, PC Gøtzsche, RT O'neill, DG Altman, K Schulz, ... Annals of internal medicine 141 (10), 781-788, 2004 | 1648 | 2004 |
Is screening for breast cancer with mammography justifiable? PC Gøtzsche, O Olsen The Lancet 355 (9198), 129-134, 2000 | 1390 | 2000 |
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies M Erik von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... Ann Intern Med 147 (8), 573, 2007 | 1091* | 2007 |
Cochrane review on screening for breast cancer with mammography O Olsen, PC Gøtzsche The Lancet 358 (9290), 1340-1342, 2001 | 1067 | 2001 |
Placebo interventions for all clinical conditions A Hróbjartsson, PC Gøtzsche Cochrane database of systematic reviews, 2004 | 1025 | 2004 |
Increasing value and reducing waste: addressing inaccessible research AW Chan, F Song, A Vickers, T Jefferson, K Dickersin, PC Gøtzsche, ... The Lancet 383 (9913), 257-266, 2014 | 911 | 2014 |
Systematic reviews I Chalmers, D Altman, P Gotzsche London: BMJ Publishing Group, 1995 | 793 | 1995 |
Rational diagnosis and treatment HR Wulff The Journal of medicine and philosophy 11 (2), 123-134, 1986 | 757* | 1986 |